PD-L1 expression on tumor cells as a potential predictive biomarker for patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy followed by durvalumab - Käsmann, Lukas; Nieto, Alexander; Taugner, Julian; Manapov, Farkhad (Translational Cancer Research, 2023)